Phyllis Zee, MD, PhD, and Alon Avidan, MD, MPH, provide an overview of behavioral and pharmacological approaches to the management of excessive daytime sleepiness (EDS) and narcolepsy and discuss the recent approval of agents with new mechanisms of action.
EP. 4: Differential Diagnosis of Patients with NarcolepsyMarch 15th 2021
Key opinion leaders review reasons for diagnostic delay in narcolepsy including medical and psychiatric comorbidities and discuss diagnostic tools such as sleep diaries, polysomnograms, and cerebrospinal fluid testing.
EP. 5: Behavioral Approaches to the Management of NarcolepsyMarch 22nd 2021
Experts in neurology discuss the goals of treatment and consider behavioral approaches to the management of narcolepsy and idiopathic hypersomnia including naps and exposure to sunlight.
EP. 7: Recent Approvals of Pitolisant and Solriamfetol for EDSMarch 29th 2021
Experts in neurology review the recent approvals of pitolisant and solriamfetol for the management of excessive daytime sleepiness (EDS) and compare their mechanisms of action.
EP. 9: Future Improvements in the Management of NarcolepsyApril 5th 2021
Expert neurologists discuss advancements in the management of narcolepsy including new drug formulations and provide take-home messages for how to improve diagnosis and treatment in the future.